Clinical Trial Update: Sildenafil for Prevention of Cerebral Vasospasm [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating sildenafil to prevent cerebral vasospasm after subarachnoid hemorrhage was withdrawn. The study was conducted at a Porto Alegre ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Rupture of Intracranial Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 2 | Status: WITHDRAWN